PharmAkea Inc. is a privately held San Diego-based biopharmaceutical company whose focus is to discover and develop small molecule therapeutics directed at cancer and fibrotic diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/07/13 | $10,000,000 | Series A |
Bay City Capital Celgene Corporation | undisclosed |
